Candice Willmon

843 total citations
17 papers, 683 citations indexed

About

Candice Willmon is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Candice Willmon has authored 17 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Candice Willmon's work include Virus-based gene therapy research (12 papers), CAR-T cell therapy research (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Candice Willmon is often cited by papers focused on Virus-based gene therapy research (12 papers), CAR-T cell therapy research (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Candice Willmon collaborates with scholars based in United States, United Kingdom and India. Candice Willmon's co-authors include Richard G. Vile, Timothy Kottke, Kevin J. Harrington, Alan Melcher, Rosa María Díaz, Jill Thompson, Peter J. Selby, Robin Prestwich, Phonphimon Wongthida and Glen N. Barber and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Journal of Molecular Biology.

In The Last Decade

Candice Willmon

15 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Candice Willmon United States 11 566 409 272 133 132 17 683
Shyambabu Chaurasiya United States 18 414 0.7× 406 1.0× 203 0.7× 124 0.9× 128 1.0× 33 636
Assia L. Angelova Germany 14 582 1.0× 440 1.1× 250 0.9× 104 0.8× 115 0.9× 34 733
Zahari Raykov Germany 13 544 1.0× 358 0.9× 234 0.9× 115 0.9× 97 0.7× 21 650
Minna Oksanen Finland 17 726 1.3× 666 1.6× 367 1.3× 187 1.4× 210 1.6× 24 884
Suvi Parviainen Finland 13 478 0.8× 436 1.1× 223 0.8× 118 0.9× 160 1.2× 20 594
Mathilde Feist Germany 10 398 0.7× 439 1.1× 234 0.9× 97 0.7× 203 1.5× 15 665
Murielle Gantzer France 8 620 1.1× 400 1.0× 544 2.0× 77 0.6× 209 1.6× 13 915
Roshni Ravindranathan United States 12 727 1.3× 805 2.0× 337 1.2× 157 1.2× 432 3.3× 17 1.1k
Margaret R. Duffy United Kingdom 14 500 0.9× 445 1.1× 386 1.4× 83 0.6× 134 1.0× 25 705
Mohan Kuppuswamy United States 13 816 1.4× 388 0.9× 677 2.5× 135 1.0× 92 0.7× 20 977

Countries citing papers authored by Candice Willmon

Since Specialization
Citations

This map shows the geographic impact of Candice Willmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candice Willmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candice Willmon more than expected).

Fields of papers citing papers by Candice Willmon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Candice Willmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candice Willmon. The network helps show where Candice Willmon may publish in the future.

Co-authorship network of co-authors of Candice Willmon

This figure shows the co-authorship network connecting the top 25 collaborators of Candice Willmon. A scholar is included among the top collaborators of Candice Willmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Candice Willmon. Candice Willmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gore, John L., et al.. (2025). Clinical characteristics and treatment patterns of patients with muscle invasive bladder cancer: A real-world cohort study.. Journal of Clinical Oncology. 43(5_suppl). 698–698.
2.
Morgans, Alicia K., Guru Sonpavde, Phoebe Wright, et al.. (2024). REAL-WORLD ELIGIBILITY AND UTILIZATION OF AVELUMAB MAINTENANCE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA. Urologic Oncology Seminars and Original Investigations. 42. S26–S27.
3.
Morgans, Alicia K., Phoebe Wright, Zsolt Hepp, et al.. (2024). Real-World Treatment Patterns and Clinical Outcomes in Patients With Locally Advanced or Metastatic Urothelial Carcinoma by Eligibility for Maintenance Avelumab. Clinical Genitourinary Cancer. 23(1). 102270–102270. 1 indexed citations
4.
Morgans, Alicia K., Matthew D. Galsky, Phoebe Wright, et al.. (2023). Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility. Urologic Oncology Seminars and Original Investigations. 41(8). 357.e11–357.e21. 12 indexed citations
5.
Sonpavde, Guru, Matt D. Galsky, Phoebe Wright, et al.. (2022). Real-world treatment patterns and clinical outcomes with first-line therapy in cisplatin-eligible and ineligible patients with advanced urothelial carcinoma.. Journal of Clinical Oncology. 40(16_suppl). 4565–4565. 7 indexed citations
6.
Willmon, Candice, et al.. (2016). Sickle Cells Abolish Melanoma Tumorigenesis in Hemoglobin SS Knockin Mice and Augment the Tumoricidal Effect of Oncolytic Virus In Vivo. Frontiers in Oncology. 6. 166–166. 5 indexed citations
7.
Ilett, Elizabeth J., Timothy Kottke, Oliver Donnelly, et al.. (2014). Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus. Molecular Therapy. 22(10). 1851–1863. 55 indexed citations
8.
Willmon, Candice, Rosa María Díaz, Phonphimon Wongthida, et al.. (2010). Vesicular Stomatitis Virus-induced Immune Suppressor Cells Generate Antagonism Between Intratumoral Oncolytic Virus and Cyclophosphamide. Molecular Therapy. 19(1). 140–149. 28 indexed citations
9.
Willmon, Candice, Kevin J. Harrington, Timothy Kottke, et al.. (2009). Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy. Molecular Therapy. 17(10). 1667–1676. 135 indexed citations
10.
Willmon, Candice, Vassiliki Saloura, Zvi G. Fridlender, et al.. (2009). Expression of IFN-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma. Cancer Research. 69(19). 7713–7720. 88 indexed citations
11.
Kottke, Timothy, Jill Thompson, Rosa María Díaz, et al.. (2009). Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2. Clinical Cancer Research. 15(2). 561–569. 63 indexed citations
12.
Kottke, Timothy, Rosa María Díaz, Karen M. Kaluza, et al.. (2008). Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer. Molecular Therapy. 16(12). 1910–1918. 40 indexed citations
13.
Korkegian, Aaron, Candice Willmon, Andressa Ardiani, et al.. (2008). Yeast Cytosine Deaminase Mutants with Increased Thermostability Impart Sensitivity to 5-Fluorocytosine. Journal of Molecular Biology. 377(3). 854–869. 29 indexed citations
14.
Qiao, Jian, Timothy Kottke, Rosa María Díaz, et al.. (2008). Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors. Gene Therapy. 15(8). 604–616. 76 indexed citations
15.
Willmon, Candice, Django Sussman, & Margaret E. Black. (2008). The Role of Herpes Simplex Virus-1 Thymidine Kinase Alanine 168 in Substrate Specificity. PubMed. 2(1). 60–66. 8 indexed citations
16.
Qiao, Jian, Timothy Kottke, Candice Willmon, et al.. (2007). Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. Nature Medicine. 14(1). 37–44. 117 indexed citations
17.
Willmon, Candice, et al.. (2006). A guanylate kinase/HSV-1 thymidine kinase fusion protein enhances prodrug-mediated cell killing. Gene Therapy. 13(17). 1309–1312. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shyambabu Chaurasiya Breakdown of academic impact, for papers by Assia L. Angelova Breakdown of academic impact, for papers by Zahari Raykov Breakdown of academic impact, for papers by Minna Oksanen Breakdown of academic impact, for papers by Suvi Parviainen Breakdown of academic impact, for papers by Mathilde Feist Breakdown of academic impact, for papers by Murielle Gantzer Breakdown of academic impact, for papers by Roshni Ravindranathan Breakdown of academic impact, for papers by Margaret R. Duffy Breakdown of academic impact, for papers by Mohan Kuppuswamy
Rankless by CCL
2026